Who is sponsoring NCT06561672?

NCT06561672 is sponsored by Zagazig University.

What drugs are being tested in NCT06561672?

Interventions in NCT06561672: tramadol plus paracetamol, Fentanyl, propofol and muscle relaxant (cisatracurium), Propofol.

What condition does NCT06561672 study?

NCT06561672 studies Preemptive Paracetamol Plus Tramadol and Preemptive Fentanyl.

Is NCT06561672 still recruiting?

NCT06561672 is currently enrolling by invitation. Last updated 20 August 2024.

Last reviewed 2024-08-20 · How we verify

NCT06561672

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Paracetamol Plus Tramadol Versus Fentanyl As Preemptive Analgesia For Enhanced Recovery After Day Case Surgeries

ENROLLING BY INVITATION EARLY_PHASE1 Last updated 20 August 2024

What this trial tests

EARLY_PHASE1 trial testing tramadol plus paracetamol in Preemptive Paracetamol Plus Tramadol and Preemptive Fentanyl in 102 participants. Enrolling by invitation.

Timeline

1 September 2024

Primary endpoint
20 March 2025

20 June 2025

Quick facts

Lead sponsor	Zagazig University
Phase	EARLY_PHASE1
Status	ENROLLING BY INVITATION
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	102
Start date	1 September 2024
Primary completion	20 March 2025
Estimated completion	20 June 2025
Sites	1 location across Egypt

Drugs / interventions tested

tramadol plus paracetamol — full drug profile →
Fentanyl (fentanyl) — full drug profile →
propofol and muscle relaxant (cisatracurium) — full drug profile →
Propofol (Propofol) — full drug profile →

Conditions studied

Preemptive Paracetamol Plus Tramadol and Preemptive Fentanyl — all drugs for Preemptive Paracetamol Plus Tramadol and Preemptive Fentanyl →

Sponsor

Zagazig University

Who can join

Adults 21 to 65, any sex, with Preemptive Paracetamol Plus Tramadol and Preemptive Fentanyl. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Implementation of enhanced recovery in day case surgeries using either preemptive intravenous paracetamol plus tramadol or preemptive intravenous fentanyl.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Zagazig University trials

Trials by the same sponsor.

NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06561672 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zagazig University
Last refreshed: 20 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06561672.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing